| Cash |
| Accounts receivable, net of $8,000 allowance for doubtful accounts at June 30, 2011 and September 30, 2010 |
291K |
| Costs and estimated earnings in excess of billings on uncompleted contracts |
92K |
| Inventories |
384K |
| Prepaid expenses and other current assets |
218K |
| Total current assets |
1.52M |
| Property and equipment, net |
1.52M |
| Patents and trademarks, net |
| Reorganization value in excess of amounts allocated to identifiable assets |
| Other assets |
495K |
| Total assets |
43.21M |
| Accounts payable |
714K |
| Customer deposits |
1K |
| Accrued liabilities |
335K |
| Notes payable, related party |
| Current maturities of long term debt |
15K |
| Total current liabilities |
1.28M |
| Long term debt, less current maturities |
302K |
| Long term debt, related party |
700K |
| Interest payable |
| Derivative liabilities |
| Total liabilities not subject to compromise |
| Liabilities subject to compromise (Note 10) |
| Total liabilities |
2.54M |
| Commitments and contingencies (Note 14) |
0 |
| Preferred stock, $.01 par value, 50,000,000 shares authorized; no shares issued and outstanding |
0 |
| Common stock, $.01 par value, 300,000,000 shares authorized; 143,575,225 and 98,149,783 issued and outstanding at June 30, 2011 and September 30, 2010 respectively |
1M |
| Additional paid-in capital |
43.24M |
| Accumulated deficit |
-3.57M |
| Total stockholders' deficit attributable to Biovest International, Inc. |
40.67M |
| Non-controlling interests |
-5K |
| Total stockholders' deficit |
40.67M |
| Total liabilities and stockholders' deficit |
43.21M |
